Log in or Sign up for Free to view tailored content for your specialty!
Genitourinary Cancer News
Cancer survivors at higher medium-, long-term risk for cardiovascular disease
Survivors of most types of cancers demonstrated increased medium- to long-term risk for at least one cardiovascular disease compared with the general population, according to results of a retrospective study published in The Lancet.
CDC: Vaccine could have prevented 92% of HPV cancers
CDC data showed that most of the estimated 34,800 cancers yearly attributed to HPV annually between 2012 and 2016 could have been prevented if the patient had received the 9-valent HPV vaccine.
Log in or Sign up for Free to view tailored content for your specialty!
Teratoma linked to higher cumulative incidence of germ cell tumor-related death
Teratoma appeared associated with a higher cumulative incidence of disease-related death among men with nonseminomatous germ cell primary tumors, according to results of a retrospective study published in Journal of Clinical Oncology.
Adjuvant radiotherapy prolongs biochemical RFS for certain men with prostate cancer
Men with prostate cancer with positive surgical margins or extracapsular extension achieved longer biochemical RFS after radical prostatectomy with adjuvant radiotherapy compared with surgery alone, according to results of a randomized Finnish study published in European Urology.
Are there feasible alternatives to BCG for the effective treatment of bladder cancer?
Click here to read the Cover Story, “BCG: a real-world example of health care rationing.”
BCG: a real-world example of health care rationing
Bacillus Calmette-Guérin, or BCG, is highly effective at treating and preventing recurrence of early-stage bladder cancer.
Research initiative aims to better understand link between immunotherapy, type 1 diabetes
The Parker Institute for Cancer Immunotherapy, in collaboration with the Juvenile Diabetes Research Foundation and Helmsley Charitable Trust, have formed a cancer and diabetes research initiative to better understand the association between immunotherapy treatment and subsequent risk for type 1 diabetes.
Atezolizumab-chemotherapy combination prolongs PFS in advanced bladder cancer
The addition of atezolizumab to platinum-based chemotherapy extended PFS among patients with previously untreated advanced bladder cancer, according to results released by the agent’s manufacturer.
Nivolumab with higher ipilimumab dose shows promising efficacy for bladder cancer
Nivolumab showed durable antitumor activity among patients with metastatic urothelial carcinoma, both alone and combined with ipilimumab, according to extended follow-up from the CheckMate 032 study.
Single-port robotic surgery shows promise for urologic cancers and beyond
The most effective and preferred treatment for many cancers remains surgery, and surgical techniques continue to evolve with the rest of the cancer care arsenal.
-
Headline News
‘Please talk about it’: Patients with heart disease want more guidance on sexual health
November 26, 20242 min read -
Headline News
Breast calcification on mammogram ‘especially predictive’ of CVD risk in younger women
November 26, 20243 min read -
Headline News
Q&A: How to talk to families about vaccines
November 26, 20245 min read
-
Headline News
‘Please talk about it’: Patients with heart disease want more guidance on sexual health
November 26, 20242 min read -
Headline News
Breast calcification on mammogram ‘especially predictive’ of CVD risk in younger women
November 26, 20243 min read -
Headline News
Q&A: How to talk to families about vaccines
November 26, 20245 min read